Company: SLGN
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000849869-25-000072
Chunk: 16

Company: SILGAN HOLDINGS INC
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
9 million, $252.6 million and $303.7 million at March 31, 2025 and 2024 and December 31, 2024, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

Note 10.               Retirement Benefits 

The components of the net periodic pension benefit cost for the three months ended March 31 were as follows:20252024 (Dollars in thousands)Service cost$1,944 $2,165 Interest cost8,119 8,413 Expected return on plan assets(10,257)(10,771)Amortization of prior service cost 8 23 Amortization of actuarial losses1,893 1,852 Net periodic benefit cost $1,707 $1,682  The components of the net periodic other postretirement benefit cost for the three months ended March 31 were as follows:20252024(Dollars in thousands)Service cost$4 $7 Interest cost151 165 Amortization of prior service credit(15)(5)Amortization of actuarial gains(86)(84)Net periodic benefit cost $54 $83 

Note 11.               Income Taxes

Silgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2023 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2024 and 2025 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing. 

-14-

SILGAN HOLDINGS INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Information at March 31, 2025 and 2024 and for thethree months then ended is unaudited)

Note 12.               Treasury Stock

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. We did not repurchase any shares of our common stock pursuant to this authorization during the three months ended March 31, 2025.